News

Analysis of Recent Options Activity for Pfizer (PFE)

Analysis of Recent Options Activity for Pfizer (PFE)

Exploring Pfizer's Options Activity

Lately, Pfizer has caught the eye of investors, particularly those with significant purchasing power, often called whales, who are showing a clear bearish sentiment. By examining the trends in options trading for Pfizer (PFE), we identified a total of 26 trades that reflect a mix of market expectations.

Among these trades, it’s notable that 46% of investors took positions with bullish hopes, while 50% leaned towards a bearish outlook. This division highlights a significant split in opinions on the future direction of the stock. The overall monetary volume for these trades includes 9 puts totaling around $523,182, compared to 17 calls valued at approximately $1,209,045.

Analyzing Expected Price Movements

After delving into trading volumes and open interest data, the prevailing consensus among key market players indicates that Pfizer’s stock price is expected to range between $18.0 and $35.0 over the last three months. This zone is reflective of important market strategies and expectations.

Examining Volume and Open Interest Trends

A closer look at volume and open interest provides useful insights to assess the liquidity and public interest surrounding Pfizer's options. Understanding these parameters is key for identifying strategic entry points for investors looking to buy or sell options. Below, we summarize trends from the past month concerning volume and open interest, particularly focusing on significant strike prices within the previously mentioned $18.0 to $35.0 range.

Insights from Recent Options Activity

Data from the last 30 days sheds light on Pfizer's options activity and reveals significant discussions and potential actions that stakeholders might consider.

Current Stock Performance

Currently, Pfizer’s trading volume sits at 8,648,223 shares, with its stock price experiencing a slight increase of 0.19%, now at $29.36. The Relative Strength Index (RSI) indicates that the stock may be nearing an overbought status, adding complexity for investors.

Analysts are closely monitoring these market indicators, especially with the upcoming earnings report expected in about 35 days, which could affect future trading strategies.

Analyst Insights on Pfizer’s Stock

Recently, two financial analysts have shared their assessments of Pfizer, converging towards a targeted price of $45. Nevertheless, opinions are varied, with some advising caution as they look ahead.

Deciphering Market Dynamics

Some analysts have revised their evaluations, with one from Cantor Fitzgerald lowering their rating to Overweight while adjusting the price target to $45. This shift emphasizes the need to continuously observe market trends.

Investor Considerations

While options trading can be intricate and carries inherent risks, the potential benefits can be quite appealing. Savvy traders often manage risks by enhancing their understanding, adapting strategies, and staying alert to market changes. For anyone keen on making well-informed investment decisions or wanting to stay current on Pfizer's options trading, receiving real-time alerts can be especially helpful.

Frequently Asked Questions

What is unusual options activity in the context of Pfizer?

Unusual options activity refers to significant trades that indicate how investors feel about potential stock price movements, often reflecting stronger market beliefs.

How do the recent trades reflect investor sentiment on Pfizer?

The recent trades show a split opinion among investors, where nearly half are taking bullish positions while the remainder is bearish.

What does the price range of $18.0 to $35.0 mean for Pfizer?

This price range signifies the overall expectations of market participants regarding Pfizer’s stock movement over the past quarter.

Why is volume and open interest important in options trading?

Volume represents the total number of options contracts traded, while open interest shows the total number of outstanding contracts, both of which are critical for assessing liquidity and market interest.

What should investors consider following the analysts' ratings on Pfizer?

Investors are encouraged to stay informed about market trends and analyst viewpoints while also considering their personal risk tolerance when trading Pfizer options.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

DJI Puts 3D Conservation Tools to Work Across Segovia

Updated Category News Views 59

Stone monuments do not care about marketing slogans; they care whether somebody notices the crack before winter gets hold of it. That is why DJI’s World Heritage 3D Conservation Initiative in Segovia lands as more than a shiny drone-company ceremony. The company gathered winning 3D fly-through work from its first initiative, but the useful bit was the case for turning...

Continue Reading
Freedom Debt Relief Earns Service Recognition in 2026

Updated Category News Views 143

A Service Badge Carries Weight in a Rough Business Debt settlement is not a business where a pleasant phone voice alone gets the job done. People arrive carrying unsecured balances, anxiety, and usually a fair amount of distrust. That is why CNBC Select naming Freedom Debt Relief its “Best for Customer Service” is more meaningful than the usual chest-thumping...

Continue Reading
First Grade Literacy Push Deserves a Harder Look Now

Updated Category News Views 16

A reading gap can become a concrete wall before anyone bothers measuring it. That is the uncomfortable point behind Ignite Reading's First Grade Promise, and it deserves more attention than another polished education announcement usually gets. At a Nov. 5 Convene 2026 gathering in Boston, 56 district and literacy leaders from six states focused on getting children reading...

Continue Reading
Borr’s Q3 Presentation Puts Jack-Up Investors on Watch

Updated Category News Views 70

Jack-up drilling is a rough business to judge from a calendar invite, but Borr Drilling has put a useful marker in the sand. The company is scheduled to present financial results for the three and nine months ended September 30, 2026, at 09:00 New York time, or 15:00 CET, on Thursday, November 19. For holders of BORR, this is less about ceremonial webcast chatter and more...

Continue Reading
Nvidia Faces SEC Probe Report and New Lawsuit Stakes

Updated Category News Views 114

Silicon Valley's favorite growth machine has stumbled into the sort of fog investors hate most: regulatory questions, leadership upheaval, and a stock-price reaction with no clean answer attached. Reports cited in the lawsuit update say the Securities and Exchange Commission has opened a civil probe into NVIDIA's investor disclosures following former CEO Jensen Huang's...

Continue Reading
LiberNovo's European Black Friday Sale Tests Demand

Updated Category News Views 139

A €1,339 chair has no business pretending it is an impulse buy, which is exactly why LiberNovo’s Black Friday push deserves a closer look. The Hong Kong-based ergonomic-chair seller has rolled out its Black Friday sale across the European Union and United Kingdom, with the campaign ending November 30 at 23:59 CET in the EU and 23:59 GMT in the UK. This is a...

Continue Reading
Vanguard's Digital Win Matters More Than a Trophy

Updated Category News Views 47

A wealth manager’s website rarely earns applause, but a bad one can sure as hell lose trust fast. Vanguard’s move to No. 1 from No. 3 in the 2025 ranking for advised-investor website satisfaction is worth noticing because it hits the unglamorous part of wealth management that clients actually live with: checking accounts, understanding a plan, moving cash, and...

Continue Reading
Banks Face a Choice: Retreat or Fund Climate Resilience

Updated Category News Views 122

A flooded field can turn a prudent loan book into a social retreat overnight. That is the uncomfortable nerve in the Global Alliance for Banking on Values paper unveiled at COP31 in Antalya on November 19, 2026. Banks have become very practiced at mapping physical climate exposure, raising prices, tightening standards and stepping away. Fine, risk discipline matters. But...

Continue Reading
LiberNovo's Black Friday Chair Sale Tests Premium Demand

Updated Category News Views 81

Ergonomic chairs are not impulse purchases, and LiberNovo knows it. Its Black Friday push in the United States and Canada runs through November 30, throwing discounts, gifts, prize-wheel entries and loyalty points at buyers considering a fairly expensive piece of office equipment. That is a lot of promotional machinery for a chair sale, but the underlying pitch is...

Continue Reading
Africa’s Digital Ownership Debate Gets More Serious

Updated Category News Views 64

Ownership was the uncomfortable word hanging over Cape Town on day two of Africa Tech Festival 2026, and frankly it should make investors sit up. Africa’s digital economy has no shortage of big promises, shiny AI demos or overseas executives talking about opportunity. The harder question is who funds the pipes, owns the data, makes the rules and actually keeps the...

Continue Reading

Top 5 Most Recently Viewed Articles

FirstEnergy Reports Strong Q3 2024 Financial Outcomes

Updated Category News Views 232

Strong Third Quarter Earnings Performance FirstEnergy Corp. recently revealed impressive financial results for the third quarter of 2024, showcasing GAAP earnings from continuing operations at $419 million. This translates to earnings per share of $0.73, demonstrating slight retention from the previous year's earnings of $421 million, which were $0.74 per share on...

Continue Reading
Apple Delays Apple Intelligence in EU Over DMA Concerns

Updated Category Business Views 583

Apple Delays Launch of Apple Intelligence in EU Due to Regulatory Hurdles The European Union launch of Apple Intelligence AI product will be delayed, the company said. The "regulatory uncertainties" pertaining to the Digital Markets Act (DMA) of the EU are the cause of the delay. Apple voiced worries that the DMA might jeopardize the quality of their offerings. Keeping...

Continue Reading
AMVital Turmeric Soap Achieves Top Sales and Customer Satisfaction

Updated Category News Views 219

AMVital Turmeric Soap Surges in Popularity AMVital, a prominent name in turmeric skincare, has made waves in the beauty market. Their Turmeric Kojic Acid Soap Bar recently secured the top spot on Walmart Marketplace, outpacing competitors and earning substantial consumer trust. Exceptional Customer Feedback This innovative soap has amassed over 13,000 verified reviews...

Continue Reading
ChemoMetec Expands Its Portfolio with Ovizio Acquisition

Updated Category News Views 90

ChemoMetec Acquires Ovizio Imaging Systems SA ChemoMetec has taken an important step by submitting a binding tender offer for the complete acquisition of Belgian company Ovizio Imaging Systems SA. This decision comes after careful consideration and a thorough due diligence process. Details of the Acquisition The acquisition is set at a price of EUR 2,830,000. Exciting...

Continue Reading
Tether's Vision: Dirham-Pegged Stablecoin and More

Updated Category News Views 135

Tether's New Dirham-Pegged Stablecoin Initiative During a recent interview, Tether CEO Paolo Ardoino provided valuable insights about the company’s latest developments. One of the key announcements was the upcoming launch of a stablecoin pegged to the UAE's currency, the Dirham. The introduction of this stablecoin reflects Tether's commitment to adapting to the evolving...

Continue Reading